Gene expression profiling in lymph node-positive and lymph node-negative pancreatic cancer - PubMed (original) (raw)
Gene expression profiling in lymph node-positive and lymph node-negative pancreatic cancer
Han Na Kim et al. Pancreas. 2007 Apr.
Abstract
Objectives: The purpose of this study was to screen for genes related to lymph node metastasis by comparing the differences in the expression profile between pancreatic cancer with lymph node metastasis and one without, and to predict the invasiveness and the progression of pancreatic cancer on the basis of these findings.
Methods: The total RNA of the tissues was extracted from 10 pancreatic cancer specimens, including those with lymph node metastasis and those with no metastasis. It was studied by means of a DNA microarray (oligo chip) consisting of 37,842 genes. We screened out 1.5-fold or more differential gene expressions in at least 5 pairs of samples. We classified both samples and genes using a 2-way clustering analysis. The screened-out genes were identified using real-time polymerase chain reaction.
Results: We identified 194 genes, including 66 overexpressed and 128 underexpressed genes, in pancreatic cancer with lymph node metastasis. Among them, we identified some genes related to lymph node metastasis in patients with pancreatic cancer: oncogenes, tumor suppressor genes, apoptosis and antiapoptosis genes, tumor angiogenesis factors, and cell cycle regulators. Genes promoting the growth of tumor cells were highly expressed in lymph node-positive pancreatic cancer, whereas genes inducing apoptosis were underexpressed.
Conclusions: We have identified genes that may play an important role in metastasis and survival in patients with pancreatic cancer. These results provide new insight into the study of human pancreatic cancer metastasis, including lymph node metastasis, and ultimately may lead to improving early diagnosis and discovering innovative therapeutic approaches for cancer.
Similar articles
- Gene expression profiling in lymph node-positive and lymph node-negative colorectal cancer.
Kwon HC, Kim SH, Roh MS, Kim JS, Lee HS, Choi HJ, Jeong JS, Kim HJ, Hwang TH. Kwon HC, et al. Dis Colon Rectum. 2004 Feb;47(2):141-52. doi: 10.1007/s10350-003-0032-7. Dis Colon Rectum. 2004. PMID: 15043283 - [Screening of differential expression genes between primary breast cancer and its lymph node metastasis using single primer amplification of cDNA for microarray].
Hao XS, Feng YM, Zhang L, Li XQ, Niu Y, Xiao CH, Sun BC. Hao XS, et al. Zhonghua Yi Xue Za Zhi. 2005 Feb 16;85(6):385-90. Zhonghua Yi Xue Za Zhi. 2005. PMID: 15854527 Chinese. - RGS16 and FosB underexpressed in pancreatic cancer with lymph node metastasis promote tumor progression.
Kim JH, Lee JY, Lee KT, Lee JK, Lee KH, Jang KT, Heo JS, Choi SH, Rhee JC. Kim JH, et al. Tumour Biol. 2010 Oct;31(5):541-8. doi: 10.1007/s13277-010-0067-z. Epub 2010 Jun 23. Tumour Biol. 2010. PMID: 20571966 - Systematic review of the clinical significance of lymph node micrometastases of pancreatic adenocarcinoma following surgical resection.
Choi SB, Han HJ, Park P, Kim WB, Song TJ, Choi SY. Choi SB, et al. Pancreatology. 2017 May-Jun;17(3):342-349. doi: 10.1016/j.pan.2017.03.008. Epub 2017 Mar 18. Pancreatology. 2017. PMID: 28336226 Review. - Molecular mechanism underlying lymphatic metastasis in pancreatic cancer.
Xiao Z, Luo G, Liu C, Wu C, Liu L, Liu Z, Ni Q, Long J, Yu X. Xiao Z, et al. Biomed Res Int. 2014;2014:925845. doi: 10.1155/2014/925845. Epub 2014 Jan 22. Biomed Res Int. 2014. PMID: 24587996 Free PMC article. Review.
Cited by
- Pro-oncogenic function of HIP-55/Drebrin-like (DBNL) through Ser269/Thr291-phospho-sensor motifs.
Li Z, Park HR, Shi Z, Li Z, Pham CD, Du Y, Khuri FR, Zhang Y, Han Q, Fu H. Li Z, et al. Oncotarget. 2014 May 30;5(10):3197-209. doi: 10.18632/oncotarget.1900. Oncotarget. 2014. PMID: 24912570 Free PMC article. - Molecular markers associated with outcome and metastasis in human pancreatic cancer.
Van den Broeck A, Vankelecom H, Van Eijsden R, Govaere O, Topal B. Van den Broeck A, et al. J Exp Clin Cancer Res. 2012 Aug 27;31(1):68. doi: 10.1186/1756-9966-31-68. J Exp Clin Cancer Res. 2012. PMID: 22925330 Free PMC article. - Study of Clinical Survival and Gene Expression in a Sample of Pancreatic Ductal Adenocarcinoma by Parsimony Phylogenetic Analysis.
Nalbantoglu S, Abu-Asab M, Tan M, Zhang X, Cai L, Amri H. Nalbantoglu S, et al. OMICS. 2016 Jul;20(7):442-7. doi: 10.1089/omi.2016.0059. OMICS. 2016. PMID: 27428255 Free PMC article. - RNA sequencing analyses reveal novel differentially expressed genes and pathways in pancreatic cancer.
Mao Y, Shen J, Lu Y, Lin K, Wang H, Li Y, Chang P, Walker MG, Li D. Mao Y, et al. Oncotarget. 2017 Jun 27;8(26):42537-42547. doi: 10.18632/oncotarget.16451. Oncotarget. 2017. PMID: 28418924 Free PMC article. - A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma.
Stratford JK, Bentrem DJ, Anderson JM, Fan C, Volmar KA, Marron JS, Routh ED, Caskey LS, Samuel JC, Der CJ, Thorne LB, Calvo BF, Kim HJ, Talamonti MS, Iacobuzio-Donahue CA, Hollingsworth MA, Perou CM, Yeh JJ. Stratford JK, et al. PLoS Med. 2010 Jul 13;7(7):e1000307. doi: 10.1371/journal.pmed.1000307. PLoS Med. 2010. PMID: 20644708 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical